FindTrial
Sign In

Treatment and molecular analysis of bullous pemphigoid with tofacitinib: a case report and review of current literature

Treatment and molecular analysis of bullous pemphigoid with tofacitinib: a case report and review of current literature

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091549
Enrollment
Unknown
Registered
2024-10-30
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bullous pemphigoid

Interventions

Case group:None

Sponsors

The First Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients with refractory bullous pemphigoid

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Time to reach clinical remission;—

Countries

China

Contacts

Public ContactMingwang Zhang

The First Affiliated Hospital of Army Medical University, PLA

mingwangzhang2@163.com+86 23 68766338

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026